Image

RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation

Recruiting
21 years of age
Both
Phase N/A

Powered by AI

Overview

Spinal Cord Injury (SCI), being a devastating diagnosis, has little to no recovery which leads to a long-standing of debilitating impairment for affected patients. The National Neuroscience Institute (NNI) Neurosurgery team, together with our collaborators, will be embarking on a new clinical pilot trial named RESTORES: RESToration of Rehabilitative function with Epidural Spinal Stimulation. This study aims to investigate the feasibility of electrical stimulation via a spinal cord stimulator (SCS), which will be implanted into the study subjects, and advanced robotic neuro-rehabilitation to aid in improving neurological function in patients diagnosed with chronic SCI. A total of 3 patients, male and female participants, above the age of 21 who have been diagnosed with the condition for more than a year will be recruited for this study over a 2-year period. Rehab sessions will take place pre and post-surgical implant, assessing subject improvements.

Description

Motor complete SCI is defined as American Spinal Injury Association (ASIA) impairment Grade A or B, with no motor function preserved below the level of injury. This in-turn results in significant catastrophic dysfunction and disability to the individual's physical and mental health, reducing quality of life and increasing caregiver burden which translates to high socioeconomic costs. The current treatments for chronic SCI involves aggressive rehabilitation to maximize residual neurological function and devices to compensate for neurological loss. However, neurological improvement is dismal, with 94.4% of patients demonstrating no neurological improvement 5-years post-injury. Experimental and electrophysiological observations revealed that spinal networks have the capacity to generate basic locomotor rhythmicity without supraspinal input to the cord. SCS, consisting of a small array of electrodes surgically implanted into the spinal epidural space stimulates afferent sensory pathways in specific patterns to drive voluntary and autonomically controlled motor responses. Activity-based training in conjunction with SCS has been shown to bolster neuroplasticity and recovery caudal to the injury site. The investigators aim to deliver epidural spinal stimulation via an implanted SCS and together with personalized advanced neuro-rehabilitation to study the improvement of neurological function after chronic SCI.

Eligibility

⦁ Inclusion Criteria

        For inclusion in the study, the potential patient has to fulfil all of the following
        criteria:
          1. 21 years old and older
          2. Chronic (greater than one year) motor complete (AIS classification A or B) SCI
          3. Spinal injury between the levels of Thoracic 2 (T2) to Lumbar 1 (L1)
          4. Segmental reflexes that remain functional below the level of lesion
          5. Able to perform the perioperative rehabilitation program as judged by the research
             team
               -  Exclusion Criteria
        Potential patients will be excluded from the trial if they fulfil any of the following
        criteria:
          1. Significant medical co-morbidities that would significantly increase the risk of the
             operation
          2. Severe dysautonomia with systolic blood pressure fluctuation less than 50 or more than
             200mmHg on tilt table testing
          3. Painful musculoskeletal dysfunction, contractures, unhealed fractures, pressure sores,
             severe spasticity, and osteoporosis
          4. Significant psychological issues or ongoing drug abuse
          5. Pregnancy and lactating patients
          6. Progressive spinal cord disease

Study details

Chronic Spinal Cord Injury

NCT05644171

National Neuroscience Institute

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.